Cryo-Cell(CCEL.US)

Chmn Portnoy Buys 3,990 ($16.2K) Of Cryo-Cell International Inc [CCEL]

Portnoy David Chairman of the Board of Cryo-Cell International Inc [CCEL] filed a Form 4 on November 19, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:Date11/17/25-11/19/25TransactionPurchaseShares3,990Price$4.05Value$16,171Ending Holdings: 1,699,043 (846,540 - Direct, 852,503 - Indirect) For a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

Cryo-Cell International Inc. will not declare a quarterly cash dividend for Q4 2025

Cryo-Cell International Inc. has announced that it will not declare a quarterly cash dividend for the fourth quarter of fiscal 2025. No dividend will be distributed for this period.

Cryo-Cell International Amends Credit Agreement and Extends Loan Maturities with Susser Bank

Cryo-Cell International Inc. has amended its credit agreement with Susser Bank, extending the maturity of its revolving credit facility to October 18, 2027, with a limit of $8 million. The term loan maturity is now set for July 29, 2032. The amendment includes the addition of Celle Corp. as a guarantor and adjustments to interest margins based on the Base Rate and Monthly SOFR, along with a commitment fee of 0.25% per annum.

Cryo-Cell | 10-Q: FY2025 Q3 Revenue Misses Estimate at USD 7.825 M

Cryo-Cell International Reports Q3 2025 Revenue of $7.83 Million and Net Income of $749,000

Cryo-Cell International Inc. reported Q3 2025 revenues of $7.83 million, down 3% from $8.07 million in Q3 2024. The net income for the quarter was $749,000, a decrease from $1.05 million in the same period last year. This financial update highlights a decline in both revenue and net income year-over-year.